NASDAQ: EVGN
Evogene Ltd Stock Ownership - Who owns Evogene?

Insider buying vs selling

Have Evogene Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EVGN insiders and whales buy or sell their stock.

EVGN Shareholders

What type of owners hold Evogene Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC4.38%456,587$233.77kInstitution
Leon Recanati0.81%83,886$42.95kInsider
Jane Street Group LLC0.18%18,500$9.47kInstitution
Xtx Topco Ltd0.12%12,721$6.51kInstitution
Two Sigma Securities LLC0.12%12,465$6.38kInstitution
Daytona Street Capital LLC0.09%9,586$4.91kInstitution
Bnp Paribas Financial Markets0.09%9,124$4.67kInstitution
Ubs Group Ag0.06%6,352$3.25kInstitution
Yaron Eldad0.04%4,100$2.10kInsider
Morgan Stanley0.04%3,851$1.97kInstitution

1 of 2

EVGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVGN5.10%0.84%
CLGN10.60%4.63%
MLEC0.48%99.52%
MBIO6.70%13.37%Net SellingNet Selling
SNGX0.25%99.75%Net Buying

Evogene Stock Ownership FAQ

Who owns Evogene?

Evogene (NASDAQ: EVGN) is owned by 5.10% institutional shareholders, 0.84% Evogene insiders, and 94.06% retail investors. Leon Recanati is the largest individual Evogene shareholder, owning 83,886.00 shares representing 0.81% of the company. Leon Recanati's Evogene shares are currently valued at $42.78k.

If you're new to stock investing, here's how to buy Evogene stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.